These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 37487659)

  • 21. 1,25-dihydroxyvitamin D3 and its receptor inhibit the chenodeoxycholic acid-dependent transactivation by farnesoid X receptor.
    Honjo Y; Sasaki S; Kobayashi Y; Misawa H; Nakamura H
    J Endocrinol; 2006 Mar; 188(3):635-43. PubMed ID: 16522742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of human class I alcohol dehydrogenases by bile acids.
    Langhi C; Pedraz-Cuesta E; Haro D; Marrero PF; Rodríguez JC
    J Lipid Res; 2013 Sep; 54(9):2475-84. PubMed ID: 23772048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Farnesoid X receptor responds to bile acids and represses cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription.
    Chiang JY; Kimmel R; Weinberger C; Stroup D
    J Biol Chem; 2000 Apr; 275(15):10918-24. PubMed ID: 10753890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bile acid-induced negative feedback regulation of the human ileal bile acid transporter.
    Neimark E; Chen F; Li X; Shneider BL
    Hepatology; 2004 Jul; 40(1):149-56. PubMed ID: 15239098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological activation of the bile acid nuclear farnesoid X receptor is feasible in patients with quiescent Crohn's colitis.
    van Schaik FD; Gadaleta RM; Schaap FG; van Mil SW; Siersema PD; Oldenburg B; van Erpecum KJ
    PLoS One; 2012; 7(11):e49706. PubMed ID: 23189156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Farnesoid X receptor, through the binding with steroidogenic factor 1-responsive element, inhibits aromatase expression in tumor Leydig cells.
    Catalano S; Malivindi R; Giordano C; Gu G; Panza S; Bonofiglio D; Lanzino M; Sisci D; Panno ML; Andò S
    J Biol Chem; 2010 Feb; 285(8):5581-93. PubMed ID: 20026603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulation of UGT2B4 Expression by 3'-Phosphoadenosine-5'-Phosphosulfate Synthase Knockdown: Implications for Coordinated Control of Bile Acid Conjugation.
    Barrett KG; Fang H; Cukovic D; Dombkowski AA; Kocarek TA; Runge-Morris M
    Drug Metab Dispos; 2015 Jul; 43(7):1061-70. PubMed ID: 25948711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Farnesoid x receptor ligands inhibit vascular smooth muscle cell inflammation and migration.
    Li YT; Swales KE; Thomas GJ; Warner TD; Bishop-Bailey D
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2606-11. PubMed ID: 18029909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity.
    Barbier O; Torra IP; Sirvent A; Claudel T; Blanquart C; Duran-Sandoval D; Kuipers F; Kosykh V; Fruchart JC; Staels B
    Gastroenterology; 2003 Jun; 124(7):1926-40. PubMed ID: 12806625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bile acids enhance low density lipoprotein receptor gene expression via a MAPK cascade-mediated stabilization of mRNA.
    Nakahara M; Fujii H; Maloney PR; Shimizu M; Sato R
    J Biol Chem; 2002 Oct; 277(40):37229-34. PubMed ID: 12149270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VPAC1 expression is regulated by FXR agonists in the human gallbladder epithelium.
    Chignard N; Mergey M; Barbu V; Finzi L; Tiret E; Paul A; Housset C
    Hepatology; 2005 Sep; 42(3):549-57. PubMed ID: 16037943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hematopoietically expressed homeobox is a target gene of farnesoid X receptor in chenodeoxycholic acid-induced liver hypertrophy.
    Xing X; Burgermeister E; Geisler F; Einwächter H; Fan L; Hiber M; Rauser S; Walch A; Röcken C; Ebeling M; Wright MB; Schmid RM; Ebert MP
    Hepatology; 2009 Mar; 49(3):979-88. PubMed ID: 19072826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of the farnesoid X receptor represses PCSK9 expression in human hepatocytes.
    Langhi C; Le May C; Kourimate S; Caron S; Staels B; Krempf M; Costet P; Cariou B
    FEBS Lett; 2008 Mar; 582(6):949-55. PubMed ID: 18298956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor.
    Kast HR; Goodwin B; Tarr PT; Jones SA; Anisfeld AM; Stoltz CM; Tontonoz P; Kliewer S; Willson TM; Edwards PA
    J Biol Chem; 2002 Jan; 277(4):2908-15. PubMed ID: 11706036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiatherosclerotic effect of farnesoid X receptor.
    Mencarelli A; Renga B; Distrutti E; Fiorucci S
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H272-81. PubMed ID: 19028791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diacylglycerol kinase θ couples farnesoid X receptor-dependent bile acid signalling to Akt activation and glucose homoeostasis in hepatocytes.
    Cai K; Sewer MB
    Biochem J; 2013 Sep; 454(2):267-74. PubMed ID: 23767959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic analysis of hepatic farnesoid X receptor binding sites reveals altered binding in obesity and direct gene repression by farnesoid X receptor in mice.
    Lee J; Seok S; Yu P; Kim K; Smith Z; Rivas-Astroza M; Zhong S; Kemper JK
    Hepatology; 2012 Jul; 56(1):108-17. PubMed ID: 22278336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Farnesoid X Receptor (FXR) Regulates mTORC1 Signaling and Autophagy by Inhibiting SESN2 Expression.
    Wang G; Chen L; Qin S; Geng H; Xia C; Zheng Y; Lei X; Zhang J; Wu S; Yao J; Deng L
    Mol Nutr Food Res; 2023 Mar; 67(6):e2200517. PubMed ID: 36715418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bile salt excretory pump: biology and pathobiology.
    Suchy FJ; Ananthanarayanan M
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Farnesoid X receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through downregulation of HER2 expression.
    Giordano C; Catalano S; Panza S; Vizza D; Barone I; Bonofiglio D; Gelsomino L; Rizza P; Fuqua SA; Andò S
    Oncogene; 2011 Sep; 30(39):4129-40. PubMed ID: 21499302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.